Beukenlaan 137
5616 VD Eindhoven
The Netherlands
+31 85064 55 82
info@interhospi.com
PanGlobal Media IS not responsible for any error or omission that might occur in the electronic display of product or company data.
Beukenlaan 137
5616 VD Eindhoven
The Netherlands
+31 85064 55 82
info@interhospi.com
PanGlobal Media IS not responsible for any error or omission that might occur in the electronic display of product or company data.
Early-onset dementia: New study reveals higher incidence rates
Alzheimer’s disease, dementia, incidence, neurology, Research, /in dementia, E-News, Neurology /by panglobalA groundbreaking study from Finnish researchers uncovers alarming trends in early-onset dementia among working-age adults, with Alzheimer’s disease cases nearly doubling over the past decade.
BiVACOR Total Artificial Heart: First-in-human implantation marks new era in cardiac care
Artificial Heart, BiVACOR, bridge-to-transplant, Texas Heart Institute, /in Cardiology, E-News, Editors' Picks, MedTech /by panglobalA groundbreaking titanium artificial heart with a single moving part has been successfully implanted in a patient with end-stage heart failure, potentially revolutionising treatment options for those awaiting transplantation.
New study sheds light on cellular vulnerabilities and resilience in Alzheimer’s disease
Alzheimer’s, brain, Genetics, Nature, Reelin, /in dementia, E-News, Genetics, Neurology /by panglobalA groundbreaking MIT study published in Nature offers new insights into the cellular mechanisms underlying Alzheimer’s disease, revealing potential targets for interventions to maintain cognitive function.
European project aims to improve hospital design with human-centred climate approach
climate change, Europe, healthcare-associated infections, hospital design, /in E-News, Featured Articles, Hospital Design /by panglobalThe HumanIC project, funded by the EU’s Horizon Europe programme, seeks to create a new generation of scientists and engineers who will redefine hospital environments through innovative indoor climate design.
New Code of Practice for stem cell-based embryo models addresses ethical concerns
Code of Practice, embryo models, ethics, Research, stem cell, /in E-News, Genetics /by panglobalScientists in the UK have developed the first code of practice for research using stem cell-based embryo models, providing ethical guidelines and governance for this rapidly advancing field.
New gene therapy breakthrough offers hope for Duchenne muscular dystrophy patients
Duchenne muscular dystrophy, Genetics, Nature, treatment, /in Congenital Diseases, E-News, Genetics /by panglobalA groundbreaking gene therapy for Duchenne muscular dystrophy (DMD) has demonstrated significant potential in not only arresting muscle decline but also possibly repairing damaged muscle tissue. This novel treatment, developed by researchers at UW Medicine, utilises a series of protein packets delivered via viral vectors to replace the defective DMD gene within affected muscles.
Genome editing restores hearing in mice with progressive hearing loss
CRISPR/Cas9, gene, hearing loss, /in E-News, Genetics /by panglobalResearch from Mass Eye and Ear demonstrates successful use of CRISPR/Cas9 to target and disrupt a genetic mutation causing hearing loss, offering hope for future treatments in humans.
UK study shatters myths on egg freezing success
egg freezing, fertility, pregnancy, reproductive medicine, /in E-News, Reproduction /by panglobalA landmark British study spanning 15 years has demonstrated that egg freezing success rates are comparable to routine IVF, offering reassurance to women considering this fertility preservation option.
Deepfakes of popular TV doctors are being used to sell health scams on social media
AI, deepfake, fraudulent products, scam, The BMJ, /in AI, E-News /by panglobalUK television doctors are being impersonated in AI-generated videos to promote fraudulent health products on social media, according to an investigation by The BMJ.
Scientists discover new antidote for cobra venom
antidote, cobra, heparin, snakebite, venom, /in E-News /by panglobalScientists have discovered that heparin, a common blood thinner, could be repurposed as an effective treatment for cobra venom-induced necrosis, potentially revolutionising snakebite treatment in low- and middle-income countries.